Search Results - "Zewald, R A"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients by LETTEBOER, T. G. W, ZEWALD, R. A, KAMPING, E. J, DE HAAS, G, MAGER, J. J, SNIJDER, R. J, LINDHOUT, D, HENNEKAM, F. A. M, WESTERMANN, C. J. J, PLOOS VAN AMSTEL, J. K

    Published in Human genetics (01-01-2005)
    “…Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease is an autosomal dominant disorder characterized by an aberrant vascular development…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only by Hes, F J, McKee, S, Taphoorn, M J B, Rehal, P, van der Luijt, R B, McMahon, R, van der Smagt, J J, Dow, D, Zewald, R A, Whittaker, J, Lips, C J M, MacDonald, F, Pearson, P L, Maher, E R

    Published in Journal of medical genetics (01-12-2000)
    “…OBJECTIVES Central nervous system haemangioblastoma (HAB) is a major feature of von Hippel-Lindau (VHL) disease, and it is estimated that about 30% of HAB…”
    Get full text
    Journal Article
  5. 5

    Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients by GOUW, S. C., VAN DER BOM, J. G., VAN DEN BERG, H. M., ZEWALD, R. A., PLOOS VAN AMSTEL, J. K., MAUSER-BUNSCHOTEN, E. P.

    “…The development of neutralizing antibodies against factor VIII (FVIII) is a major complication of treatment with FVIII in patients with severe haemophilia A…”
    Get full text
    Journal Article
  6. 6

    Management of renal cell carcinoma in von Hippel-Lindau disease by HES, F. J, SLOOTWEG, P. J, VAN VROONHOVEN, T. J. M. V, HENE, R. J, FELDBERG, M. A. M, ZEWALD, R. A, VAN AMSTEL, J. K. P, HÖPPENER, J. W. M, PEARSON, P. L, LIPS, C. J. M

    Published in European journal of clinical investigation (01-01-1999)
    “…Background An evaluation of nephron‐sparing surgery (NSS) or radical nephrectomy (RN) for treating renal cell carcinoma (RCC) in patients with von…”
    Get full text
    Journal Article
  7. 7

    Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers by LANDSVATER, R. M, DE WIT, M. J, ZEWALD, R. A, HOFSTRA, R. M. W, BUYS, C. H. C. M, PLOOS VAN AMSTEL, H.-K, HÖPPENER, J. W. M, LIPS, C. J. M

    Published in Cancer research (Chicago, Ill.) (01-11-1996)
    “…Germ line mutations in one allele of the RET proto-oncogene predispose to the multiple endocrine neoplasia type 2 (MEN 2) syndromes. To investigate whether…”
    Get full text
    Journal Article
  8. 8

    Short stature as the only presenting feature in a patient with an isodicentric (Y)(q11.23) and gonadoblastoma. A clinical and molecular cytogenetic study by GILTAY, Jacques C, AUSEMS, Margreet G. E. M, VAN SEUMEREN, Ineke, ZEWALD, Richard A, SINKE, Richard J, FAAS, Brigit, DE VROEDE, Monique

    Published in European journal of pediatrics (01-03-2001)
    “…A 13-year-old phenotypically female patient presented with short stature (height SDS -2.6), but without any Turner stigmata or other dysmorphic features…”
    Get full text
    Conference Proceeding Journal Article
  9. 9
  10. 10